(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
HEALTHCARE:  Michael Rea, CEO of Rx Savings Solutions, to discuss the wide gap in Mylan's EpiPen drug pricing between the UK ($69) and the US ($600.)

<p>(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
HEALTHCARE:  Michael Rea, CEO of Rx Savings Solutions, to discuss the wide gap in Mylan's EpiPen drug pricing between the UK ($69) and the US ($600.)</p>

Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

<p>Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.</p>

Alix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze markets, companies and industries.

Bloomberg Intelligence

Rx Savings’ Rea on Wide Gaps in EpiPen Drug Pricing (Audio)

Rx Savings' Rea on Wide Gaps in EpiPen Drug Pricing (Audio)

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2e102472-824e-497c-9ee1-ae3c0085e7f6/transcript

Advertisement